Sale!

CA 27.29 Breast Cancer Marker Test

Original price was: R6,000.Current price is: R4,000.

-33%

The CA 27.29 Breast Cancer Marker Test is a crucial diagnostic tool that provides peace of mind and early detection capabilities for South African women concerned about breast health. At only ZAR 4,000 (regularly ZAR 6,000), this advanced test offers exceptional value for monitoring breast cancer progression and treatment effectiveness. Using sophisticated immunoassay technology, the CA 27.29 marker specifically detects breast cancer antigens in your bloodstream, providing your healthcare team with vital information about your condition. Whether you’re currently undergoing treatment, in remission, or have concerning symptoms, this test delivers the accuracy and reliability you deserve. With nationwide coverage including Johannesburg, Cape Town, and Durban, Oracle Genomics makes professional breast cancer monitoring accessible across South Africa. Our commitment to patient care means you receive clear, understandable results backed by medical expertise. Take control of your breast health today with confidence and trust in our comprehensive testing services.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

CA 27.29 Breast Cancer Test | ZAR 4
CA 27.29 Breast Cancer Marker Test
R6,000 Original price was: R6,000.R4,000Current price is: R4,000.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

CA 27.29 Breast Cancer Marker Test: Your Partner in Breast Health Monitoring

We understand the anxiety and uncertainty that comes with breast cancer concerns. Whether you’re currently undergoing treatment, in remission, or monitoring your health proactively, the CA 27.29 test provides the clarity and confidence you need to make informed decisions about your wellbeing.

Understanding the CA 27.29 Breast Cancer Marker Test

The CA 27.29 test is a sophisticated blood analysis that measures specific proteins associated with breast cancer cells. This isn’t just another test – it’s a powerful monitoring tool that helps your medical team track treatment effectiveness, detect potential recurrence early, and guide your ongoing care plan with precision.

Using advanced immunoassay technology, we detect the presence of breast cancer antigens in your bloodstream, providing valuable insights that complement other diagnostic methods like mammograms and physical examinations.

Who Should Consider This Test?

This test is particularly important for:

  • Women currently undergoing breast cancer treatment to monitor therapy effectiveness
  • Breast cancer survivors in remission for ongoing surveillance
  • Individuals with concerning symptoms like lumps, breast changes, or persistent pain
  • Those with family history of breast cancer seeking proactive monitoring
  • Patients with metastatic breast cancer requiring treatment response assessment

If you’re experiencing any breast health concerns or want peace of mind about your monitoring strategy, this test provides the objective data you and your doctor need.

Why This Test Matters for Your Health Journey

Early detection and accurate monitoring can significantly impact breast cancer outcomes. The CA 27.29 test offers:

  • Early Recurrence Detection: Identify potential issues before they become serious problems
  • Treatment Guidance: Help your medical team adjust therapies based on your response
  • Peace of Mind: Reduce anxiety with regular, reliable monitoring
  • Personalized Care: Receive treatment plans tailored to your specific situation
  • Proactive Health Management: Take control of your breast health with data-driven insights

Understanding Your Results with Confidence

We know waiting for test results can be stressful. That’s why we provide:

  • Clear Interpretation: Easy-to-understand results with professional guidance
  • Medical Context: How your results fit into your overall health picture
  • Next Steps: Clear recommendations for follow-up actions if needed
  • Ongoing Support: Access to medical professionals who can answer your questions

Your results will be available within 2-3 weeks after sample collection, with comprehensive reporting that empowers you and your healthcare provider.

Affordable, Accessible Breast Health Monitoring

Test Option Price Value
Regular Price ZAR 6,000 Comprehensive breast cancer monitoring
Special Offer ZAR 4,000 Save ZAR 2,000 on essential health monitoring

Considering the potential health benefits and peace of mind, this test represents exceptional value in proactive breast health management.

Why Trust Oracle Genomics?

We’re committed to providing South Africans with accessible, reliable healthcare testing:

  • Nationwide Coverage: Serving patients across Johannesburg, Cape Town, Durban, Pretoria and throughout South Africa
  • Medical Expertise: Tests reviewed by qualified oncologists and gynecologists
  • Accuracy Guarantee: Advanced immunoassay technology ensures reliable results
  • Patient-Focused: We prioritize your comfort, understanding, and peace of mind
  • Convenient Process: Simple blood sample collection with clear instructions

Take Control of Your Breast Health Today

Don’t let uncertainty about your breast health create unnecessary stress. The CA 27.29 test provides the clarity and confidence you deserve.

Sample Requirements: 2 mL serum sample (minimum 0.5 mL) collected in SST tube. Please provide brief clinical history and complete the mandatory Test Send Out Consent Form (Form 35).

Important: Samples must reach us by the 7th of each month for processing.



Limited time special pricing available. Early detection saves lives – take action for your health today.